Last reviewed 2026-04-19 · How we verify

COPD Associated with Chronic Bronchitis

10 treatments

Approved treatments

Daliresp · Arcutis
Daliresp works by blocking an enzyme called phosphodiesterase 4, which helps reduce inflammation in the body.
Cutivate · Teva Pharm
Foradil · Novartis
Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing.
Flonase · GSK (GlaxoSmithKline)
Flixotide · Mundipharma Research Limited
Fluticason · Creighton University
Theophyllin · University of Bergen
Serevent · Fundacio Privada Mon Clinic Barcelona
Daxas · AstraZeneca
Aminophyllin · University of Padova

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

COPD Associated with Chronic Bronchitis patent landscape — cliff calendar, originator estates, attackable patents
COPD Associated with Chronic Bronchitis treatment landscape brief
COPD Associated with Chronic Bronchitis treatment updates RSS

Frequently asked questions about COPD Associated with Chronic Bronchitis

What drugs treat COPD Associated with Chronic Bronchitis?

Tracked treatments include Daliresp, Cutivate, Foradil, Flonase, Flixotide, Fluticason, Theophyllin, Serevent.

What is the treatment for COPD Associated with Chronic Bronchitis?

Standard treatment for COPD Associated with Chronic Bronchitis includes Daliresp, Cutivate, Foradil, Flonase, Flixotide. See the treatment landscape page for first-line, second-line and salvage options.

Treatment landscape: COPD Associated with Chronic Bronchitis patent cliff · COPD Associated with Chronic Bronchitis CI report
Treatment: Daliresp · Arcutis
Treatment: Cutivate · Teva Pharm
Treatment: Foradil · Novartis
Treatment: Flonase · GSK (GlaxoSmithKline)
Treatment: Flixotide · Mundipharma Research Limited
All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing